119 related articles for article (PubMed ID: 33061630)
1. Neutrophil-to-Lymphocyte Ratio and Its Changes are Related to Grade II-IV Glioma Recurrence.
Ma L; Li G; Wei M
Cancer Manag Res; 2020; 12():9429-9434. PubMed ID: 33061630
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Factor in Elderly Patients with High-Grade Gliomas.
Gan Y; Zhou X; Niu X; Li J; Wang T; Zhang H; Yang Y; Liu Y; Mao Q
World Neurosurg; 2019 Jul; 127():e261-e267. PubMed ID: 30898756
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with glioma.
Wang J; Xiao W; Chen W; Hu Y
EXCLI J; 2018; 17():505-512. PubMed ID: 30034313
[TBL] [Abstract][Full Text] [Related]
4. Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy.
Jin H; Zhang G; Liu X; Liu X; Chen C; Yu H; Huang X; Zhang Q; Yu J
World J Surg Oncol; 2013 May; 11():112. PubMed ID: 23705622
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Biomarker in Patients with Low-Grade Gliomas.
Tan Z; Shen L; Wu H; Deng L; Li Z; Huang X
World Neurosurg; 2019 Dec; 132():e585-e590. PubMed ID: 31442642
[TBL] [Abstract][Full Text] [Related]
6. Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy.
Romano A; Parrinello NL; Vetro C; Chiarenza A; Cerchione C; Ippolito M; Palumbo GA; Di Raimondo F
Ann Hematol; 2018 Jun; 97(6):1009-1018. PubMed ID: 29442162
[TBL] [Abstract][Full Text] [Related]
7. Utility of Preoperative Neutrophil/Lymphocyte Ratio as a New Objective Prognostic Tool in Endoscopically Treated Upper Tract Urothelial Carcinoma: A Retrospective Evaluation.
Antonucci M; Defidio L; De Dominicis M; Russo N; Nacchia A; Lombardo R; Patel A
J Endourol; 2020 Sep; 34(9):993-1000. PubMed ID: 32600070
[No Abstract] [Full Text] [Related]
8. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Patients With Meningiomas.
Kuranari Y; Tamura R; Tsuda N; Kosugi K; Morimoto Y; Yoshida K; Toda M
Front Oncol; 2020; 10():592470. PubMed ID: 33330078
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Neutrophil-to-Lymphocyte Ratio as a Predictive and Prognostic Factor for High-Grade Serous Ovarian Cancer.
Feng Z; Wen H; Bi R; Ju X; Chen X; Yang W; Wu X
PLoS One; 2016; 11(5):e0156101. PubMed ID: 27203425
[TBL] [Abstract][Full Text] [Related]
11. Preoperative neutrophil-lymphocyte ratio correlated with glioma grading and glioblastoma survival.
Weng W; Chen X; Gong S; Guo L; Zhang X
Neurol Res; 2018 Nov; 40(11):917-922. PubMed ID: 30074469
[TBL] [Abstract][Full Text] [Related]
12. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
13. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.
Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K
Oncology; 2019; 97(1):7-17. PubMed ID: 31048577
[TBL] [Abstract][Full Text] [Related]
14. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Hematologic Inflammatory Markers as Prognostic Factors in Patients with Glioma.
Bao Y; Yang M; Jin C; Hou S; Shi B; Shi J; Lin N
World Neurosurg; 2018 Nov; 119():e710-e716. PubMed ID: 30092479
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancer.
Wang X; Teng F; Kong L; Yu J
Onco Targets Ther; 2016; 9():5761-5770. PubMed ID: 27703374
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory biomarkers in prognostic analysis for patients with glioma and the establishment of a nomogram.
Yang T; Mao P; Chen X; Niu X; Xu G; Bai X; Xie W
Oncol Lett; 2019 Feb; 17(2):2516-2522. PubMed ID: 30719120
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
Wang J; Liu Y; Mi X; Shao M; Liu L
Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
[TBL] [Abstract][Full Text] [Related]
19. Changes in neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios during chemoradiation predict for survival and pathologic complete response in trimodality esophageal cancer patients.
Hyder J; Boggs DH; Hanna A; Suntharalingam M; Chuong MD
J Gastrointest Oncol; 2016 Apr; 7(2):189-95. PubMed ID: 27034785
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.
Lee S; Oh SY; Kim SH; Lee JH; Kim MC; Kim KH; Kim HJ
BMC Cancer; 2013 Jul; 13():350. PubMed ID: 23876227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
